Perikoncepcijska suplementacija folnom kiselinom - znanja, stavovi i savetodavna praksa farmaceuta i farmaceutskih tehničara u Srbiji by Zeković, Milica T. et al.
Vojnosanit Pregl 2019; 76(10): 1127–1138. VOJNOSANITETSKI PREGLED Page 1127 
Correspondence to: Milica Zeković, University of Belgrade, Institute for Medical Research, Centre of Research Excellence in Nutrition 
and Metabolism, Tadeuša Košćuška 1, 11 158 Belgrade, Serbia. E-mail: zekovicmilica@gmail.com 
O R I G I N A L  A R T I C L E  
  
 UDC: 615.15:[615.851.4:616-084 
https://doi.org/10.2298/VSP171226020Z
Periconceptional folic acid supplementation: knowledge, attitudes and 
counselling practice of Serbian pharmacists and pharmacy technicians 
Perikoncepcijska suplementacija folnom kiselinom: znanja, stavovi i 
savetodavna praksa farmaceuta i farmaceutskih tehničara u Srbiji  
 
Milica Zeković*, Dušanka Krajnović†, Marina Nikolić*, Tatjana Stojković†, 
Mirjana Gurinović*, Marija Glibetić* 
University of Belgrade, Institute for Medical Research, *Centre of Research  
Excellence in Nutrition and Metabolism, Belgrade, Serbia; University of Belgrade, 




Background/Aim. The protective effect of periconcep-
tional folic acid supplementation in reducing the risk of 
neural tube defects (NTDs) and other adverse pregnancy 
outcomes has been scientifically confirmed. The present 
study aimed to assess knowledge, attitudes, and practice 
(KAP) of community pharmacists and pharmacy techni-
cians with regards to counselling women of reproductive 
age on adequate folate intake. Methods. The cross-sec-
tional study was conducted among the nationwide stratified 
sample of pharmacists and pharmacy technicians, practicing 
in both private and state-owned community pharmacies in 
Serbia. The detailed literature review, expert consultation 
and pre-testing were employed in the questionnaire devel-
opment. The descriptive and inferential statistical analyses 
were performed using the SPSS software ver. 22. Results. 
Among 730 survey participants, 96.6% correctly identified 
types of deformities that could be prevented by folic acid 
and 77.0% recognized recommended dosage for women 
capable of becoming pregnant. However, fewer were able to 
recognize the optimal timing for folic acid supplementation 
(61.1%) and the proper dose for the NTD recurrence pre-
vention (42.9 %). While 43.2% of pharmacy technicians 
thought that it was not their responsibility to provide a 
counselling concerning the measures for the prevention of 
congenital anomalies, only 4.7% of licensed pharmacists and 
none of the interns were of that opinion (χ2 = 198.287; df = 
4; p < 0.001). The majority of respondents (54.7%) reported 
provision of informative consultation concerning folic acid 
once a week, or few times a month, while only 10 stated to 
do so on a daily basis. In addition, based on self-report, only 
36.7% of participants communicates information and advice 
regarding adequate folate status at their own initiative, while 
the rest addresses this topic only on the patients request, 
i.e., reactively. Conclusion. Although participants acknowl-
edged the importance of their role in preconception health 
promotion, our findings revealed certain knowledge gaps as 
well as dominantly reactive counselling practice. Tailored 
educational interventions and professional support are 
needed to improve the engagement of community phar-
macy personnel in this area of public health. 
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Uvod/Cilj. Naučno je potvrđen zaštitni efekat primene su-
plemenata folne kiseline u perikoncepcijskom periodu u re-
dukciji rizika od nastanka defekata nervne cevi (DNC) i 
drugih neželjenih ishoda trudnoće. Cilj ove studije bio je is-
pitivanje znanja, stavova i prakse farmaceuta i farmaceutskih 
tehničara zaposlenih u javnim apotekama u vezi sa saveto-
vanjem žena reproduktivne dobi o adekvatnom unosu fola-
ta. Metode. Sprovedenom studijom preseka obuhvaćen je 
nacionalni stratifikovani uzorak farmaceuta i farmaceutskih 
tehničara zaposlenih u državnim i privatnim javnim apote-
kama u Srbiji. Detaljan pregled literature, ekspertske konsul-
tacije i pre-testiranje primenjeni su u procesu razvoja upitni-
ka. Deskriptivna i inferencijalna statistička analiza realizova-
ne su primenom SPSS softvera ver. 22. Rezultati. Od 730 
ispitanika, 96,6% tačno je identifikovalo vrste deformiteta 
koji se mogu prevenirati primenom folne kiseline, a 77,0% 
prepoznalo je preporučenu dozu za žene sposobne da osta-
nu u drugom stanju. Ipak, manji udeo ispitanika prepoznao 
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je optimalni vremenski okvir za suplementaciju (61,1%), kao 
i adekvatnu dozu za prevenciju rekurence DNC (42,9%). 
Dok je 43,2% farmaceutskih tehničara izrazilo uverenje da 
nije njihova obaveza da sprovode savetovanje o merama za 
prevenciju kongenitalnih anomalija, takvo mišljenje imalo je 
samo 4,7% licenciranih farmaceuta i nijedan farmaceut-
stažer (χ2 = 198.287; df = 4; p < 0,001). Većina učesnika 
studije (54,7%) izjavila je da pruža informativne konsultacije 
u vezi folne kiseline jednom nedeljno ili nekoliko puta 
mesečno, a samo 10 ispitanika tvrdilo je da to čini svako-
dnevno. Dodatno, na osnovu sopstvenog izveštaja, samo 
36,7% ispitanika pruža savete i informacije o adekvatnom 
statusu folata na sopstvenu inicijativu, dok ostatak ovu temu 
pominje samo na zahtev pacijenta tj. reaktivno. Zaključak. 
Iako su ispitanici prepoznali značaj sopstvene uloge u pro-
mociji zdravlja u prekoncepcijskom periodu, naši rezultati 
ukazali su na određene propuste u znanju i dominantno re-
aktivan pristup savetovanju. Prilagođene edukativne inter-
vencije i profesionalna podrška neophodni su za unapre-
đenje javnozdravstvenog angažovanja farmaceutskog tima iz 
javnih apoteka u ovoj oblasti. 
 
Ključne reči: 
farmaceutske službe, javne; farmaceuti; farmaceutski 
pomoćnici; zdravlje, znanje, stavovi, praksa; folna 
kiselina; trudnoća; srbija. 
 
Introduction 
Nutritive deficiencies are well-recognized preventable risk 
factors for the development of congenital anomalies and other 
adverse pregnancy outcomes. A protective effect of the pericon-
ceptional folic acid supplementation in reducing the risk for both 
occurrence and recurrence of neural tube defects (NTDs) is sci-
entifically confirmed through many observational and interven-
tional studies 1. Folate derivatives are involved as coenzymes in 
the single-carbon transfer of units in the metabolism of amino 
acids and synthesis and reparation of nucleic acids. Accordingly, 
the role of this water-soluble B9 vitamin is of a special impor-
tance for the intense cell maturation, division and proliferation 
during embryogenesis 2. 
Teratogenic effect of folate deficiency is particularly in-
tensive during the process of neurulation occurring in early 
gestation phases, namely, in the first 28 days after concep-
tion 3. Consequently, the timing for folic acid supplementa-
tion is critical. The fact that over 40% of pregnancies world-
wide are unplanned indicates that this process, essential for 
proper development of the foetal nervous system, occurs be-
fore most women even become aware of the pregnancy 4. 
That is the reason why great efforts have been made globally 
to create efficient public health strategies and interventions 
focused on folate intake and status optimization in all women 
of reproductive age 5–7. 
Due to the problematic stability and limited bioavail-
ability of folate native forms from natural sources, it is rec-
ommended that all women capable of becoming pregnant 
should take 400 µg of the synthetic form of the vitamin, i.e., 
folic acid daily via oral supplements and/or fortified foods as 
an addition to varied and nutritionally balanced diet. Espe-
cially high risk level is recognized in women with the NTD-
affected pregnancies in their reproductive history, women us-
ing anticonvulsive therapy and those with diagnosed diabe-
tes. Thus, they are recommended to take substantially higher 
(medicinal) doses of folic acid, i.e. 4–5 mg and to be under 
medical supervision 8–10. 
However, regardless the unequivocal epidemiological 
evidence, achieved scientific consensus on the folic acid 
benefits in ensuring healthy offspring, and the fact that many 
health authorities officially recommended the use of folic ac-
id prior to conception and during early phases of pregnancy, 
numerous studies revealed suboptimal intake of this essential 
nutrient among the women of reproductive age 5, 11, 12. 
The variability of the situation in different countries is affected 
by a number of factors such as the awareness of women of preven-
tion measures for NTDs, the existence, application and coverage of 
strategies for improving folate intake and status in the targeted 
population group, the availability and affordability of folic acid sup-
plements, and finally, the population exposure to folic acid – forti-
fied foods 13–15. In the absence of fortification, educational cam-
paigns and programs directed towards the promotion of adequate 
periconceptional care are crucial, while the responsibility and role of 
healthcare professionals are especially emphasized. 
Serbia, like the majority of European countries, has re-
frained from establishing the mandatory folic acid fortifica-
tion policy, and the availability of voluntarily fortified prod-
ucts is quite modest. Recently conducted study among the 
Serbian women of childbearing potential pointed to the alar-
mingly low level of folate intake. Based on an analysis of di-
etary questionnaires (24h dietary recalls and food frequency 
questionnaire – FFQ), the folate intake was below recom-
mended levels in more than 90% of studied women. Fur-
thermore, folate concentration in erythrocytes associated 
with the optimal protection against neural tube defects (i.e., 
906 nmol/L) was not recorded in any of the examinees. Pre-
vious findings that less than 5% of women in reproductive 
age takes the folic acid supplements on regular basis was ad-
ditionally confirmed 16, 17. In such a context, the necessity of 
public health initiatives and efficient interventions directed 
to the optimization of nutritive status of women prior to their 
pregnancy and during it is clearly evident. 
Healthcare professionals, being reliable members of the 
community, may significantly contribute to the improvement 
of maternal and newborns’ health by the delivery of timely, 
accurate and evidence-based information and advice. Phar-
macists and pharmacy technicians are ideally positioned 
within the health care system to promote the periconcep-
tional folic acid supplementation and to participate in the 
health education of women of reproductive age. Unique ac-
cessibility of community pharmacies provides a strategically 
significant platform for achieving the greater coverage of 
targeted population group. Dissemination of health-promotional 
messages regarding folic acid and stimulation of women to 
apply preventive measures is supported by the International 
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Pharmaceutical Federation (FIP). This organization, through 
policies and recommendations complying with the World 
Health Organization (WHO) Maternal, Newborn and Child 
Health Interventions, emphasizes the role and responsibility 
that pharmacists bear in the context of reaching child mortal-
ity and maternal health targets set forth by the United Na-
tions Millennium Development Goals four and five 18, 19. In 
order to efficiently address public health needs, it is essential 
for the community of pharmacy professionals to have posi-
tive perception of the importance of preconception care-
related activities as well as the adequate knowledge, skills 
and motivation to integrate them into everyday work practice. 
The aim of the present study was to assess the knowledge, 
attitudes, and practice (KAP) of Serbian community pharma-
cists and pharmacy technicians with regard to counselling the 
women of reproductive age on adequate folate intake. 
Methods 
Study design, setting and study participants 
A questionnaire-based cross-sectional study was con-
ducted from October 2015 to December 2016 among the na-
tionwide stratified sample of licensed pharmacists and phar-
macy technicians, working both in private and state-owned 
community pharmacies in Serbia. 
To ensure that a number of survey participants is ade-
quate to represent 5,803 registered pharmacists in Serbia, a 
sample size calculation procedure proposed by Krejcie and 
Daryle 20 was used. The required sample size as per formula 
(n = 385) was adjusted to the anticipated drop-out rate (d = 
20%) using the equation N = n/ (1–d/100) resulting in a total 
of N = 481 subjects 21. 
The Pharmaceutical Chamber of Serbia membership di-
rectory was used as a sampling frame and the geographical 
quotas were established in order to obtain the sample propor-
tional to the actual distribution of community pharmacists on 
a national scale. Accordingly, the sample was divided into 
four strata corresponding to the regional Chamber branches: 
Belgrade, the capital city (37.92%), Vojvodina, the northern 
autonomous province (21.83%), Kragujevac, representing 
Central and Western Serbia (23.19%) and Niš with Kosovo 
and Metohija, representing the Southern and Eastern Serbia 
(17.04%). Participation in the study was offered to all phar-
macy technicians and interns working in the same pharma-
cies as recruited pharmacists. 
 
Data collection 
After obtaining the consent of the director, or owner of 
the pharmacy, the self-administered questionnaires in a hard-
copy format were hand-delivered to designated respondents 
in predefined time, so as not to disturb the regular daily op-
erations. Participation in the study was voluntary, and the 
questionnaires were submitted anonymously. The survey 
packs included a cover letter, study information sheet, ethical 
statement and the copy of the survey instrument. During the 
questionnaires were filled-in, a researcher remained available 
in case of any further questions, or concerns. The informed 
consent was assumed by completion of the questionnaire and 
no incentives were offered to the respondents. 
 
Questionnaire 
The survey instrument, developed for the purpose of 
this study, was based on the detailed literature review and 
expert consultation. An expert group discussed the initial set 
of questions and selected the final assemblage in order to en-
sure that all relevant domains were covered. An eleven-
member panel including five experienced pharmacists, four 
experts in the field of nutrition, psychologist and a statisti-
cian evaluated the face and content validity parameters of the 
questionnaire, i.e., item relevancy, comprehensibility, clarity 
and sequence; instrument organization, terminology and 
completeness 22. For further refinement, the draft version was 
pre-tested among 10 pharmacists and 7 pharmacy technicians 
practicing in community pharmacies. Necessary amend-
ments, dominantly wording and layout were made in accor-
dance with their feed-back to ensure acceptability and proper 
understanding of the questions and instructions. A pilot study 
was then conducted with the convenience sample (n = 56) of 
pharmacists and pharmacy technicians to assess the study 
feasibility and instrument reliability. The Cronbach’s alpha 
values yielded for both knowledge and attitudes sections of 
the questionnaire were satisfactory, i.e., above the apriory set 
threshold of 0.7 (αknowledge = 0.823; αattitudes = 0.789) indicating 
a good internal consistency. 
The final version of the questionnaire consisted of 4 
sections. Section 1 gathered the respondents’ sociodemo-
graphic and professional data such as gender, age, highest 
professional credential, work experience, marital status and 
details regarding the practicing setting (pharmacy type, own-
ership and location). Knowledge was assessed by 13 multi-
ple-choice questions with a single correct answer. Attitudes, 
explored by 14 statements, were captured using 5-point rat-
ing of the Likert scale (1 = strongly disagree, 2 = disagree, 3 
= neutral, 4 = agree and 5 = strongly agree). The practice 
section of the questionnaire, containing 15 items with a com-
bination of multiple-choice and the Likert-scale type re-
sponse format covered the following topics: sources of in-
formation on folate, the current practice in advising women 
about an adequate intake of folate and the barriers to regular 
provision of information and advice about folate intake in 
community pharmacies. 
 
Data processing and statistical analyses 
The descriptive and inferential statistical analyses were 
performed using the Statistical Package for Social Science 
(SPSS) software (IBM SPSS Statistics for Windows, Version 
22.0. Armonk, NY: IBM Corp.). The numerical data were 
reported as frequencies for the categorical variables and 
mean ± standard deviation (SD) for the continuous variables. 
Every correct answer in the knowledge test was credited with 
one point. The total knowledge score, representing the sum-
marised value for all the listed items, had a theoretical range 
from 0 to 13 points. The group differences for continuous va-
riables were analysed using the Student's t-test and ANOVA 
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(with the Tukey’s post hoc test), while the χ2 test was em-
ployed for the categorical variables. A level of significance 
for all statistical tests was previously set at p < 0.05. 
Ethical approval 
The study was conducted in accordance with the princi-
ples of the Declaration of Helsinki and standards for health-
related research involving human participants proposed by 
the World Health Organization 23 with the institutional re-
view and ethical approval granted by the Ethics Committee 
for Clinical Trials, Faculty of Pharmacy – University of Bel-
grade (Dossier no. 261/2). 
Results 
Among 481 licensed pharmacists, 87 intern pharmacists 
and 256 pharmacy technicians who were approached during 
the recruitment stage 461, 77 and 218 respectively, voluntar-
ily agreed to participate in the study, yielding 91.7% of con-
sent rate. All the returned questionnaires were reviewed for 
completeness and those missing the data on the main out-
come variables (n = 28) were excluded from further analyses 
resulting in a total number of 730 valid questionnaires (re-
sponse rate = 88.6%; completeness rate = 92.9%). The final 
analytical cohort of pharmacists did not differ significantly 
with respect to the original Pharmaceutical Chamber direc-
tory with a reference to geographical distribution of partici-
pants (χ2 = 4.810; df = 3; p = 0.186). 
Among the respondents, regardless the geographical re-
gion, there were more females than males (p < 0.001). The 
mean age of participants was 37.3 ± 10.3 years (range: 21.0–
66.0 years) and, on average, they had 12.4 ± 9.9 years 
(range: 0.5–40.0 years) of working experience in community 
pharmacies. Within-stratum and overall summaries of the 
participants’ sociodemographic and professional profile is 
presented in Table 1. 
The mean score on the knowledge test for the entire 
study cohort was 7.27 ± 1.95 points with the empirical range 
of 1–12 points. The majority of participants (24.4%) had 7 
correct answers and none achieved a maximum of theoretical 
score of 13 points. The analyses revealed that women were 
more knowledgeable than men (7.49 ± 1.91 vs. 6.31 ± 1.86; t 
= 43.614; p < 0.0001) just as were the respondents employed 
in the privately owned community pharmacies than those 
practising in the state-owned pharmacies (7.65 ± 2.01 vs. 
6.84 ± 1.80; t = 32.817; p < 0.001). The participants who 
were parents scored higher on the knowledge test than those 
without children (7.66 ± 1.75 vs. 6.82 ± 2.07; t = 35.679; p < 
0.001), while the respondents older than 50 years of age 
demonstrated the lower knowledge level (6.14 ± 1.79) than 
their younger colleagues: M21–30years = 7.36 ± 2.16; M31–40years 
= 7.72 ± 1.97; M41–50years = 6.99 ± 1.29 [F(3.726) = 18.504; p 
< 0.001]. The analyses of variance showed that the effect of 
professional status on knowledge was significant [F(2.727) = 
50.757; p < 0.001]: the pharmacy technicians had lower av-
erage score (6.14 ± 1.97) than the intern pharmacists (8.00 ± 
1.67) and the licensed pharmacists (7.60 ± 1.82). Corre-
spondingly, the lower level of educational attainment was as-
sociated with the lower knowledge scores [F(2.727) = 
59.391; p < 0.001]. The participants with secondary educa-
tion had notably the lower scores (6.18 ± 1.96) than the indi-
viduals with university (7.42 ± 1.76) and post-graduate edu-
cation (8.26 ± 1.80). Furthermore, the marital status had a 
significant impact on knowledge regarding the folic acid 
supplementation [F(3.715) = 26.280; p < 0.001]; the married 
and the respondents living common law scored higher (7.61 
± 1.66 and 8.11 ± 2.67 respectively) than the single and di-
vorced/separated participants (6.68 ± 2.03 and 6.09 ± 1.29 
respectively). Distribution of correct response rates regarding 
folic acid supplementation across the professional groups of 
pharmacy staff is presented in Table 2. 
The majority (n = 545; 74.6% of the total sample) of 
study participants had generally positive attitude towards 
health benefits of folic acid supplementation. Fewer phar-
macy technicians (58.7%) than the licensed pharmacists 
(79.3%) and intern pharmacists (82.4%) acknowledged con-
genital anomalies as a major public health problem in view 
of their mortality and morbidity rates (χ2 = 46.460; df = 4; p 
< 0.001). All three groups of pharmacy staff expressed con-
cern over the low level of informedness about the role of fo-
lic acid and proper use among the women of reproductive 
age in Serbia. Accordingly, a vast majority of respondents 
(95.7% females and 98.6% males) agreed that it was impor-
tant to increase women’s awareness regarding the folic acid 
value in preventing the foetal neural tube defects. While 
43.2% of pharmacy technicians thought that it was not their 
responsibility to provide counselling concerning the meas-
ures for the prevention of congenital anomalies only 4.7% of 
licensed pharmacists and none of the interns were of that 
opinion (χ2 = 198.287; df = 4; p < 0.001). Similarly, the sub-
stantially higher percentage of pharmacy technicians (37.4%) 
than the licensed and intern pharmacists (13.1% and 0%, re-
spectively) considered the patients in the community phar-
macies uninterested in being educated about the dietary sup-
plements that are used in preconception and prenatal care (χ2 
= 81.342; df = 4, p < 0.001). More males than females 
(64.0% vs. 30.8%) reported discomfort with bringing up the 
issues of family planning and the prevention of neural tube 
defects in the community pharmacy setting (χ2 = 60.552; df = 
2; p < 0.001). Furthermore, the male participants were more 
prone to believe that the use of folic acid-containing dietary 
supplements contributed to pregnancy medicalisation (53.3% 
vs. 37.1%; χ2 = 40.167; df = 2; p < 0.001). 
The frequency distribution of respondents’ attitudes 
across the professional groups of pharmacy staff is presented 
in Figure 1. 
The majority of respondents (n = 399; 54.7% of the total 
sample) reported the provision of informative consultation con-
cerning pre- and post-conception use of folic acid once a week, 
or few times a month, while only 10 (all licensed pharmacists) 
stated to do so on a daily basis. By contrast, 69.9% confirmed 
dispensing contraceptive preparations, vitamin and mineral die-
tary supplements, ovulation tests/fertility monitors and home 
pregnancy tests to women of reproductive age once daily or 
multiple times a day (Table 3).  
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The pharmacists (49.2%) were more likely than the 
pharmacy technicians (32.5%) to report a prior training on 
folic acid health protective benefits (χ2 = 9.496; df = 2; 
p < 0.01), and the vast majority of subjects (n = 630; 91.9%) 
expressed an interest in receiving the additional education on 
this issue. The main sources of information, used by the re-
spondents to expand and update their folic acid-related 
knowledge are listed in Table 3. Among the survey partici-
pants 254 (34.8%) confirmed availability of informative ma-
terials (e.g., brochures, posters, flyers, etc.) about folic acid 
and/or recommended vitamin/mineral intake preconception 
and during pregnancy in the pharmacy. Based on the self-
report, 36.7% of respondents, on most occasions, communi-
cated information and advice concerning folic acid at their 
own initiative, while 63.3% dominantly did it reactively, i.e., 
in response to the patients’ questions. The communication 
strategy was significantly associated with gender (χ2 = 12.43; 
df = 2; p < 0.001) and the current professional status 
(χ2 = 10.289; df = 4; p < 0.01). The females were more likely 
to act proactively than the males (39.8% vs. 23.7%), so as 
were the licensed and intern pharmacists (40.2% and 42.5% 
respectively) compared to the pharmacy technicians (27.7%). 
The participants’ perceptions of the most common barriers to 
regular provision of advice and information regarding the 
folate intake are presented in Table 3. 
Discussion 
Being highly accessible and trusted health profession-
als, community pharmacists have both professional responsi-
bility and opportunity to participate actively in disease pre-
vention and health promotion 24. Additionally, the evolving 
role of pharmacy technicians may support community phar-
macists in providing advanced services, including those re-
lated to the public health promotion 25, 26. During the routine 
interactions with women of reproductive age members of 
pharmacy staff can recognize and address biomedical and 
behavioural risk factors that may jeopardize women’s health 
and cause adverse pregnancy outcomes 8. Despite conclusive 
scientific evidence regarding the importance of adequate fo-
late status prior to conception and in the early phases of 
pregnancy, the folate insufficiency among women remains a 
significant public-health concern worldwide. In countries 
lacking the mandatory folic acid food fortification policies, 
like Serbia, the strategies to optimize the folate status at the 
population level are focused on the folic acid supplementa-
tion 27. The main challenge of this approach comes from the 
fact that folic acid is effective in the NTD prevention only 
during the neurulation, i.e., by 28th day post-conception. 
Due to a high rate of unplanned pregnancies, the interven-
tions aiming to increase awareness of the folic acid benefits 
and compliance with the recommendations should be di-
rected towards all women of childbearing age. By provision 
of health-education materials, informative consultation and 
advice pharmacists and pharmacy technicians may give their 
contribution in public-health efforts to combat neural tube 
defects and other preventable congenital anomalies 8. To the 
best of our knowledge, this study was the first one that ex-
plore knowledge, attitudes and practice (KAP) of the Serbian 
pharmacists and pharmacy technicians with regards to coun-
seling women of reproductive age on adequate folate intake. 
The finding that the vast majority of survey participants 
(96.6%) correctly identified the types of deformities which 
could be prevented by folic acid indicates a high level of 
general awareness of this important issue. These observa-
tions were in accordance with previous studies conducted 
among the pharmacists, pharmacy students and obstetrician-
gynecologists 28–30. Nevertheless, the study revealed certain 
gaps in the knowledge regarding some particular aspects of 
folate nutrition and the folic acid supplementation. Even 
though more than two-thirds of surveyed pharmacy staff 
members knew the recommended dietary allowances for 
adults (67%) and a dosage of folic acid for women capable 
of becoming pregnant (77%), less than one-half properly 
identified a recurrence dose and a dose for women with an 
increased risk of having infants with NTDs. The folic acid 
origin, bioavailability issues and current food fortification 
policy in Serbia were targeted as knowledge domains that 
elicited the lowest correct response rates. It is worrisome that 
almost 40% of surveyed health professionals did not recog-
nize that folic acid should be administered prior to pregnancy 
to ensure the optimal NTD prevention. This finding was di-
rectly coupled with a poor knowledge regarding the neural 
tube closure timeline. Even more significant deficiency in 
knowledge on these issues was observed among the obstetri-
cians and specialists in women’s health in the Northern Chi-
na, physicians in the Southern Israel, health professionals in 
the Northwestern Ethiopia and Chilean primary health work-
ers 31–34. The participants in the present study had the compa-
rable knowledge level to the Ohio community pharmacists 
and similar gaps were identified 28, 35. Furthermore, consis-
tent with other studies conducted among different groups of 
healthcare personnel, the professional category and educa-
tional attainment level significantly affected folic acid-
related knowledge 31, 33, 36. Based on the test results, the 
pharmacy technicians were less knowledgeable than both in-
tern and licensed pharmacists concerning the majority of 
analyzed domains. The reasons for the identified knowledge 
deficiencies should be explored and the curriculum modifica-
tions, refreshment trainings and specific guidance should be 
created accordingly. 
The majority of respondents acknowledged the impor-
tance of folic acid favourable effects on pregnancy outcomes 
and almost all expressed support to raising awareness of this 
issue among women of childbearing age. Although more 
than 40% of participants thought that folic acid contributed 
to pregnancy medicalization, in line with findings from study 
conducted in the Netherlands, that did not seem to affect 
their support to this NTD preventive measure 37. Only 2.7% 
of respondents believed that the women in Serbia are suffi-
ciently informed about the role of folate status in achieving a 
healthy offspring. Such observations of pharmaceutical staff 
members are supported with findings of previously con-
ducted studies indicating a very small proportion of Serbian 
women regularly taking the folic acid dietary supplements 16, 17. 
Similarly, alarmingly poor knowledge regarding benefits of 
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timely use of folic acid and a high rate of suboptimal peri-
conceptional practises were found in a large multinational 
survey of more than 22,000 European women of reproduc-
tive age, clearly reflecting unmet needs in preconception 
care 38. In the mentioned study, based on the participants’ 
self-report, the lack of awareness and absence of appropriate 
counselling were identified as the main reasons for not tak-
ing folic acid preconceptionally and/or during pregnancy. It 
is noteworthy that more than 90% of surveyed licensed and 
intern pharmacists agreed that the primary health care pro-
fessionals were of particular importance for preconception 
health promotion. Furthermore, comparable with the studies 
conducted among their Dutch and Australian colleagues, al-
most all responding pharmacists regarded it as their profes-
sional duty to inform women about folic acid and advocate 
for preconception care 37. The analyses of reported attitudes, 
however, revealed that 37.1% of surveyed community phar-
macy personnel expressed discomfort with discussing the is-
sues of family planning and prevention of congenital anoma-
lies, with this problem being especially accentuated among 
the male providers. In addition, 21.3%, 12.2% and 51.0% of 
licensed pharmacists, interns, and pharmacy technicians, re-
spectively, were of the opinion that these topics should be 
addressed only on patients request, i.e., reactively. Consis-
tently with other studies, the pharmacists’ concern about be-
ing too intrusive by imposing information and advice dis-
courage them from acting proactively, which causes under-
utilisation of full potential of community pharmacy setting in 
the prevention of folic acid-sensitive congenital malforma-
tions 37–41. 
In compliance with the United Nation Global Strategy 
for Women’s and Children’s Health, International Pharma-
ceutical Federation (FIP) encourages active involvement of 
pharmacists in the preservation and improvement of mater-
nal, newborn and children health through a variety of evi-
dence-informed interventions, screening, health-education, 
facilitation of health-care services and provision of appropri-
ate products 18. Nevertheless, the current study demonstrated 
a large discrepancy between the opportunities for preconcep-
tion counselling and implemented activities, highlighting the 
gap between the ideal and actual level of pharmacy staff con-
tribution. Based on the self-report, more than one-half of re-
spondents provided information and advice regarding the fo-
lic acid value in the prevention of congenital abnormalities 
once a week, or few times a month, while only 10 pharma-
cists stated to perform these activities on daily basis. Con-
versely, approximately 70% of respondents reported dispens-
ing products associated with the general and reproductive 
female health to women of childbearing age once daily, or 
even multiple times a day, which revealed a myriad of 
missed occasions for the informative consultation 40. The fact 
that a healthcare provider recommendation was recognized 
as the single most important reason women would com-
mence folic acid supplementation underscores the signifi-
cance of responsible and consistent provision of counseling 38. 
Understanding the key obstacles to the adequate delivery of 
such activities is a prerequisite for addressing suboptimal in-
volvement of the community pharmacy health professionals. 
The main barriers perceived by the surveyed pharmacists and 
pharmacy technicians were consistent with the findings from 
the studies done elsewhere and included the time and space 
constraints, low motivation level among personnel, discom-
fort with raising the issue of birth defects, lack of financial 
compensation, uncooperative patients and knowledge defi-
ciencies 39, 42–44. In order to overcome the low level of self-
assessed competency and motivation, initiate behavioral 
change and improve current and future performance of 
pharmacy staff, implementation of targeted training pro-
grammes is required. 
The theory of Planned Behaviour, as an extension of the 
Theory of Reasoned Action, has been widely applied in the 
analyses and prediction of health professionals’ behaviour 45–48. 
This theoretical framework postulates that intention, captur-
ing the motivational factors which influence behaviour, is the 
crucial antecedent and reasonably accurate predictor of an 
individual's actions 49. Based on this model, behavioural in-
tention is influenced by attitudes, subjective norms (i.e., so-
cial pressure), and perceived control over the behaviour with 
each of these variables being driven with a corresponding 
type of salient beliefs (behavioural, normative and control). 
If these social-cognitive constructs were transferred to phar-
macy practice, we might assume that the favourable attitudes 
toward preconception counselling, subjective norms support-
ing these activities and strong perceived behavioural control 
are positive and significant predictors of community phar-
macists’ and pharmacy technicians’ intentions to involve 
proactively in dissemination of evidence-informed, health-
promotional messages about folic acid. Advancement of self-
perceived knowledge, skills and efficacy would empower 
pharmacists and pharmacy technicians to embrace more ac-
tive roles in providing the patient-centered preconception 
care in accordance with their professional responsibilities 
and scope of practice 18. 
Certain limitations of the present study should be taken 
into consideration when interpreting the results. The recruit-
ment strategy applied to pharmacy technicians might have 
caused participation bias and influenced generalizability of 
the obtained results. However, the rationale behind the se-
lected sampling protocol was based on the fact that the 
pharmacy technicians perform pharmaceutical health care ac-
tivities in the community pharmacies only in the presence of 
licensed pharmacists and under their supervision. Further-
more, considering geographical distribution, no statistically 
significant difference was found between the structure of the 
analyzed cohort of pharmacy technicians and the Serbian 
Chamber of Nurses and Medical Technicians membership 
directory (χ2 = 4.315; df = 3; p = 0.229). Another limitation 
refers to the fact that the evaluation of counseling practice 
was based on the self-reported behaviour, and therefore, it 
was a subject of inherent imperfections of that method. 
Conclusion 
Given the widespread inadequacy of folate intake, a low 
level of public awareness concerning the importance of pre-
conception care and high rate of unplanned pregnancies, in-
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novative, sustainable and effective public health strategies 
are needed to reduce the risk of devastating folic acid-
preventable congenital malformations. Due to the unique ac-
cessibility and expertise community pharmacy health profes-
sionals may give indispensable contribution to this agenda. 
Nevertheless, the results of the present study provide 
evidence that tailored educational interventions and profes-
sional support are needed to improve their engagement in 
this area of public health. Although participants demon-
strated positive general attitude toward folic acid value for 
maternal and foetal health, and acknowledged the importance 
of their role in preconception health promotion, our findings 
revealed certain knowledge gaps as well as dominantly reac-
tive counselling practice. Being first to explore knowledge, 
attitudes and practice regarding folic acid supplementation 
among the pharmacists and pharmacy technicians in Serbia, 
this study provides valuable reference data for addressing the 
barriers to behavioural change, the practice optimisation and 
establishment of proactive advocacy of folic acid benefits. 
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